GlassScriptPhysician profile
William S Lynde
NPI 1104828219
$2,310.69
in general payments reported to CMS, 2019-2025
29 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $47.36 · 2021: $426 · 2022: $295 · 2023: $392 · 2024: $247 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $690.17 | 2021-2025 | Easyfuse, Prostep Mica, Viaflow |
| Paratek Pharmaceuticals, INC. | $293.51 | 2021-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $178.04 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $128.01 | 2021-2023 | Tricera Handpiece |
| Melinta Therapeutics, LLC | $113.09 | 2019 | |
| Smith+Nephew, INC. | $93.75 | 2020-2023 | Stravix Pl, Grafix Pl, Oasis |
| Liberty Surgical INC. | $91.64 | 2019 | |
| Voom Medical Devices, INC. | $73.78 | 2025 | Revcon Instrument Kit, Sterile |
| Kci USA, INC. | $72.85 | 2019 | |
| Integra Lifesciences Corporation | $62.96 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
| Urgo Medical North America, LLC | $52.75 | 2023-2025 | Urgoclean Ag, Urgok2 |
| Next Science LLC | $51.84 | 2022-2024 | Blastx, Xperience, Surgx |
| Wright Medical Technology, INC. | $45.90 | 2019-2020 | |
| Bioventus LLC | $33.13 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $30.07 | 2019-2021 | |
| Stimwave Technologies Incorporated | $29.10 | 2019 | |
| Sebela Pharmaceuticals INC. | $23.47 | 2019 | |
| Convatec INC. | $23.03 | 2023 | |
| Acumed LLC | $20.24 | 2023 | Acumed |
| Reapplix INC. | $19.40 | 2022 | |
| Nevro Corp. | $19.32 | 2023 | Senza |
| Organogenesis INC. | $18.69 | 2019 | |
| Solventum Corporation | $18.20 | 2025 | 3m Cavilon, Activ.A.C., Promogran Prisma |
| Zyla Life Sciences, INC. | $18.18 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.88 | 2019 | |
| Nabriva Therapeutics, Plc | $13.00 | 2022 | |
| Cashflow Solutions, LLC | $11.99 | 2022 | |
| Pfizer INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lynde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.